about
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver diseasePemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis.Absence of Tissue Inhibitor of Metalloproteinase-4 (TIMP4) ameliorates high fat diet-induced obesity in mice due to defective lipid absorption.Influence of different concentrations of uric acid on oxidative stress in steatosis hepatocytes.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Molecular mechanisms of fatty liver in obesity.
@en
type
label
Molecular mechanisms of fatty liver in obesity.
@en
prefLabel
Molecular mechanisms of fatty liver in obesity.
@en
P2093
P2860
P1476
Molecular mechanisms of fatty liver in obesity.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11684-015-0410-2
P577
2015-08-19T00:00:00Z
P6179
1007272784